Journavx™ (suzetrigine) – New drug approval
January 30, 2025 - The FDA announced the approval of Vertex’s Journavx (suzetrigine), for the treatment of moderate to severe acute pain in adults.
January 30, 2025 - The FDA announced the approval of Vertex’s Journavx (suzetrigine), for the treatment of moderate to severe acute pain in adults.